Immunoglobulin High Throughput Sequencing (Ig-HTS) Minimal Residual Disease (MRD) Analysis is an Effective Surveillance Tool in Patients With Mantle Cell Lymphoma

CONCLUSIONS: Our data suggest that the clonoSEQ MRD assay is an effective surveillance tool for MCL patients following first-line therapy and is predictive of relapse prior to imaging.PMID:38195321 | DOI:10.1016/j.clml.2023.12.006

Source: Clinical Lymphoma and Myeloma - January 9, 2024 Category: Cancer & Oncology Authors: Alexandra Rezazadeh Julie Pruett Amy Detzner Natasha Edwin Mehdi Hamadani Nirav N Shah Timothy S Fenske Source Type: research